GENE ONLINE|News &
Opinion
Blog

HIV
Merck’s Phase 2 HIV Treatment Study Resumes with Phase 3 Program Announcement
2022-09-20
A Cure for HIV Could Be Here Sooner Than You Think – Future of Health
2022-09-16
Gilead’s Novel Capsid Inhibitor Treatment for HIV Gains First Approval from European Commission
2022-08-22
HIV Latent Cells Could Lead to Possible Cure
2022-07-28
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
This One-Time Injection Could Cure AIDS
2022-06-21
FDA Allows Resumption of Gilead’s Lenacapavir AIDS Trials
2022-05-19
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention
2021-12-22
Experimental mRNA Vaccine Could Lead Fight Against HIV
2021-12-19
A Digital Solution Tracks Pill Adherence with 98% Accuracy
2021-12-13
Samsung Biologics Inks CDMO Deal with Enzolytics on HIV and COVID-19 Antibodies
2021-10-08
J&J’s HIV Vaccine Results Disappoint, Trial Halted But Search Continues
2021-09-01
Gilead, Merck Unite to Contest ViiV’s Cabenuva with Long-Acting HIV Therapy
2021-03-16
Gilead Reports FDA-Approved HIV Therapy Demonstrates Long-Term Efficacy
2021-03-11
1 2
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!